Stada, Angelini among final bidders for $1 bln Bristol-Myers' Upsa unit, say sources: Reuters

German drugmaker Stada and Italian healthcare company Angelini are the only industry players to be shortlisted to make final bids for Bristol-Myers Squibb’s French over-the-counter drugs business, sources told Reuters.